Feb
29

What job?

Many high-injury rate jobs that drive lots of work comp premiums and services won’t exist in ten years.  And lots of low-injury rate jobs will disappear as well.

How we prepare for this – or rather how you prepare for this – will separate the survivors from the corpses.

A bit of historical perspective; twenty-plus years ago when I worked at MetraComp, Lockheed Martin’s Fort Worth plant was a customer.  The workforce there was highly trained, averaged around 48 years old, and paid very, very well to make fighter jets.

MetraComp’s contract with LM had a big success fee baked-in.  MetraComp would be rewarded for improving disability results, and penalized – rather painfully – if future results were close to or, God forbid, below historical results.

Then the Air Force decided to stop buying new fighter jets.   The average worker had 17 years to go till retirement, was making great money, and there were zero jobs in the area that paid anything close to the hourly rate, much less provided LM’s benefits.  Add in the physical nature of the job – crawling around inside really small spaces attaching tiny parts requiring lots of repetitive movements.

The injury rate jumped, while opportunities for re-employment suddenly dried up.  MetraComp got killed.

Today, we’re looking at a future with a whole lot of Lockheed Martins.  

A robust and well-documented research project estimates almost half of US employment is at risk of disappearing.

Here’s just one industry where we’re going to see big changes.

Trucking employs 3.5 million drivers today, paid about $40k a year.  Good-paying jobs that don’t require a college degree, a rarity in today’s economy, jobs that will disappear with autonomous driving. When they do, jobs in truck stops, motels, and restaurants will dry up.  And the folks who drive the trucks and work in those truck stops, motels, and restaurants will not spend their wages in small towns, rural areas and cities.

BTW, truck driving is the most common job in 38 states…

For now, trucking is a great business.  For now.  Sure, there aren’t enough drivers today, but those jobs aren’t going to exist in 10 years.

So here’s the two questions you need to ponder.

Are you insuring/serving a thousand Lockheed Martin jet factories?

Where are you going to re-employ the truckers, hotel staff, wait staff, and mechanics? 

 


Feb
26

Work comp; two quick things

First, WCRI’s annual meeting is coming up quickly.  The fine folks from Cambridge Mass have added a second panel on opt-out.  You’ll hear from a regulator, employer, workers’ advocate and industry spokesman after listening to a “point-counterpoint” from two of the leading experts on opt-out.

For anyone who’s remotely involved in or affected by work comp, this is a must-do; you’ll get a solid education on one of THE key issues in workers’ comp.

Second, Tennessee’s adopted the ODG treatment guidelines and formulary; they go into effect Monday. More precisely, as of 2/28/16, the formulary applies to refills of scripts written before 1/1/16.  For newer prescriptions, the effective date is August 28, 2016.

Tennessee becomes the fifth state (after WA, OH, TX, OK) to adopt a drug formulary; perhaps a dozen others are working on formularies.

I’ve been far from diligent in posting of late – now that a couple projects are almost wrapped up, thing should get back to normal.  Thanks for your forbearance!


Feb
25

The future of ACA – the wonks sound off

18% of our economy is healthcare.  To know where it’s headed and how it will change, read Louise Norris’ edition of Health Wonk Review.

Louise has a plethora of posts from really smart people about the Path Forward for ACA and health reform, plus thought-provoking takes on pharma pricing, conflicts of interest, grandfathered health plans and the working person’s travails in 1915.

 


Feb
23

Tuesday’s California catch-up

Back from vacation and catching up on all the goings-on; some pretty big news out of California re work comp these days…

We’ll start with the highest impact news, and that is the California Supreme Court’s “decision” to let stand a lower court ruling that the IMR process is not unconstitutional (sorry for the double negative) AND that the IMR process does not violate an injured workers’ due process rights.

While there remain constitutional challenges to the IMR process, the Court’s decision to not review the lower court’s ruling implies these other challenges may face a similar fate.

Implication – business as usual for California.  As Court rulings supporting the IMR/UR process continue to pile up, it’s becoming increasingly clear that IMR is not going away.

Serendipitously, CWCI just released its latest analysis of IMR outcomes for 2015 (they work fast out there in Oakland!).  Here’s the need-to-knows:

  • IMR letters increased 19% from 2014 to 2015.
  • Turn-around-time (TAT) is pretty stable – and a lot faster than in 2014
  • UR decisions were upheld by IMR 88.6% of the time – essentially identical to previous results.
  • Drugs were the leading category of service appeals yet again, with opioid scripts topping the list as the drug class most-commonly appealed.  88% of denials were upheld.
  • Compounds accounted for 11% of requests; denials were upheld 98% of the time.
  • 10 physicians accounted for 34,700 IMR decisions – 11.8% of the total

Implication – Many docs are not learning – or are willfully ignoring established precedent for medical necessity/appropriateness.  The 10 docs who average 10 letters for every calendar day are jamming the system with futile requests, knowing full well that 9 out of 10 will be rejected.

Why?

As California moves to adopt a formulary next year, we may well see a rise in IMR requests when these unteachable docs continue to prescribe drugs that are inappropriate.

Thanks to Bob Young at CWCI for the heads’ up; CWCI’s take on the Court case is here.

Another item worthy of your attention – Congratulations to Rick Victor PhD; the founder and former Executive Director of WCRI has been named a Senior Fellow at the just-established Sedgwick Institute. Rick is a good friend and one of the most honorable people I know. It is great to see he will stay involved in the industry.

 

 


Feb
15

Catch up Monday

On holiday this week, hiking in Arizona.  Hope your week is fabulous, unless you are a physician dispensing advocate or opioid overuse apologist, in which case I hope it is anything but.

Speaking of which, opioid guidelines are becoming more commonplace – a welcome event indeed.  One well worth your time has been put together by the estimable Steve Feinberg MD and his colleagues.  Dr Feinberg is a practicing physician in California; he deals with a lot of chronic pain patients, many workers’ comp claimants. Note – CompPharma, the work comp PBM consortium of which I am president, participated in the guideline review process.)

Dr Adam Fein’s Drug Channels has this useful graphic detailing the US pharma distribution and reimbursement system.  Worth downloading and posting on your cube wall.

The good doctor has also penned a brief and compelling synopsis of the current drug pricing landscape, forecasting that the rampant generic price inflation of the last few years is over.

Implementing health reform

Following up on last week’s report indicating ACA’s employer mandate has not had a material effect on hours worked comes news that the expansion of Medicaid in most states has had the same “non-effect”.  Evidently there was some concern that low-paid workers would drop out of the workforce or reduce their hours once they got coverage via Medicaid; the latest research indicates that – at least so far – this does not appear to be occurring.

Work Comp

Heard last week that OneCall has (internally) announced its plans to revamp operations and detailed the impact on employees.  There will be about 150 folks affected; job responsibilities will likely change for those who remain, others will be moved to different locations, and it looks like some will lose their jobs.  This comes after the sales meeting of a few weeks ago where a shift in emphasis towards more focus on HQ sales was reportedly unveiled.

And don’t forget the WCRI Annual meeting is coming up in less than a month.  I’ll be interviewing Dr John Ruser later this week and will report back on what’s on the agenda.  Registration is here.  

Time to hit the trail – literally.


Feb
9

A mass murderer brought to justice.

A California doctor, convicted of second-degree murder was just sentenced to 30 years-to-life in prison for overprescribing opioids that resulted in the deaths of 3 “patients”.

Dr Lisa Tseng’s apparent willingness to hand out scripts to anyone with cash was going on for years and reportedly resulted in the deaths of at least a dozen patients.  Worse, she knew her patients were dying; according to news reports the County Coroner called her office at least monthly to let her know one of her patients had died.

At least a dozen of her patients died of overdoses.

Let’s call her what she is – a mass murderer.

While her motives – apparently purely financial – may have been different than the Ted Bundys, John Wayne Gacys, and Jeffrey Dahmers, her death list is not.  Nor is the impact on the families and friends of her victims.

Her defense attorney complained that the verdict was already affecting other doctors’ behavior.  I should hope so.

Another physician bemoaned the verdict, saying:

“When you use the word ‘murder,’” said Dr. Peter Staats, president of the American Society of Interventional Pain Physicians, “of course it’s going to have a chilling effect.”

Staats said he believes an aggressive medical board — not prosecutors — should go after reckless doctors. But, he added, any doctor who is prescribing pills knowing that they are being abused or diverted shouldn’t be called a doctor.

Let’s understand what’s going on here.  Some in the medical community are totally missing the point.  Over a three-year period, this “doctor” wrote some 27,000 scripts for opioids and other very dangerous drugs.  That’s about 25 each day. 

Instead of whining about “chilling effects” and the impact on doctors, these protesters should be asking themselves why 28,000 people died as a result of “accidental poisoning” due to overdoses.

They should ask themselves why heroin use has exploded.

And why it came to this.

Fortunately, the Tseng case seems to be sparking some much-needed conversation in the pain physician community.  Here’s hoping it results in a lot more caution and far fewer opioid scripts.

Thanks to good friend and colleague Sandy Blunt of Medata for the heads’ up.


Feb
8

The Super Bowl of Drugs

Warning – rant follows…

The two main takeaways from last night’s SuperBowl are:

  • A really good defense and great defensive plan can beat a really good young quarterback.
  • Drugs are where the money is.

I’ll leave the first point to those more expert in football analysis and focus on the second for a minute or two.

In a sign of the imminent arrival of the Apocalypse, there were three ads for drugs shockingly none for life-threatening conditions.  Nope, we Americans must have way bigger concerns than diabetes and cancer – namely the coming open-toe shoe season and the inner workings of our lower digestive tracts.

Yup, there was an ad for a toenail fungus cure, (TOENAIL FUNGUS?!). another for diarrhea (DIARRHEA?!) and one for Opioid-Induced Constipation.  The cheapo fungus ad cost a mere $5 million for 30 seconds; the animated intestine discussing bowel movements graced our screens for a full minute; so did Astra Zeneca’s solution for the opposite problem.

The toenail fungus AND intestine ads came courtesy of Valeant, a name you may recall from news stories about Federal investigations into its pricing practices.  Over the last few years, Valeant has bought up the rights to at least four drugs – then jacked up the drugs’ prices by a factor of 10. (this is getting to be a common practice)

And opioid-induced constipation?

Okay, that’s a problem, but WhyTF are we taking so many opioids that pharma gets to make more hundreds of millions of dollars on a problem pharma created?

What a brilliant business plan; let’s create a drug that makes people feel really good AND is highly addictive, encourage doctors to prescribe it for everything from a sore back to cancer, then, when we have saturated the market so that there’s enough pills sold to give every American a month’s supply every year, let’s charge them three hundred bucks a month so they can poop.

When you watched those ads, did you think about all the zeros on your health insurance bill this month, realize that your family deductible is about equal to what you paid for your first decent car, and see that your choice of providers is best described as “few and far between?”

We are seeing a free market system running wild.

What does this mean for you?

If we stay on this path, we’re bankrupt.

 

 

 


Feb
4

Workers’ comp is leading the way on opioids

Welcome to the war, everyone.

Okay, so work comp is not the most progressive industry. We are – often justifiably – seen as slow-moving, overly conservative, reluctant to adopt change and averse to innovation.

Except when it comes to opioids, where work comp has been far in front – and continues to lead.  By advocating for treatment guidelines, restrictions of physician dispensing of opioids, formularies tied tightly to UR, analytics and clinical intervention, work comp has long been very active in a crisis that is only now getting real attention in the “real world”.

In a shocking statistic, opioid-related deaths in this country hit 28,647 in 2014, a 9% increase over 2013,

On the “What in hell took you so long”, it is wonderful to see the President call for $1.1 billion in funds to address the opioid crisis. The mainstream media is (finally) all over the issue.  Congresspeople are strident and passionate, finally joining Rep. Hal Rodgers R KY who has long been a leader, calling for action action action.  Presidential candidates are speaking out about the crisis.  It is an acknoledged public health emergency.  The CDC is promulgating guidelines.  Meanwhile, the opioid industry and their supporters are employing all their usual tactics in an effort to keep their profits flowing – expect them to spend whatever they need to.

For those of us in work comp who have been desperately working on the issue for years, this is welcome indeed.  We’ve been fighting this battle for at least ten years, thanks to research by CompPharmaCWCI, NCCI, and WCRI. Innovative efforts by a few insurers. Passionate and vocal leadership from pharmacists and medical directors. Washington State fund L&I’s Gary Franklin MD has been the industry’s leading voice on this issue for a decade, and the progress L&I has made under his direction (kudos to Jaymie Mai, PharmD as well) has been enormous.

The American Insurance Association’s Bruce Wood has been a forceful voice for common-sense, practical solutions, tirelessly bringing this issue to the attention of legislators, regulators, comp executives, and other stakeholders

A special shout out to PBMs, where diligent, targeted, persistent effort by execs, case managers, medical directors, clinical pharmacists, data analysts and account execs have actually led to a decrease in new claims with opioids for the last two years.

Think about that.   Working with payers, PBMs have been cutting opioid scripts for new claims by 5-7 percent per year for the last two years, likely significantly reducing adverse consequences – addiction, misuse, diversion, death.

PBMs make their money when patients are prescribed and dispensed drugs.  Yet PBMs, and their payer customers, have been working tirelessly to reduce the number of pills their patients take.

I’d be remiss if I didn’t acknowledge PBMs’ customers – adjusters and execs alike – have been a key part of the solution.  I recall a terrific program instituted by OneBeacon a decade ago that rewarded adjusters for identifying claimants on opioids and referring those claimants to a physician for review and treatment modification efforts.

Somehow the uninformed and unwilling-to-be-informed out there have not seen fit to allocate credit where credit is due.

Yes, work comp can be archaic, byzantine, frustrating, and even stupid.  And yes claimants can be mis-served for any number of reasons.

But what you’ve done about opioids is truly remarkable. Yeah, we still have a long way to go.  But we are well ahead of the rest of the world.

Note – I am president of work comp PBM consortium CompPharma.

 


Feb
3

Workers’ comp – predictions for 2016

Just realized I’ve yet to post my annual Top Ten Predictions for Workers’ Comp – my apologies!

Here we go…

  1. The comp market will soften pretty much everywhere*.
    As rates continue to come in flat or a few points down, the equity markets flounder about, and interest rates stay low, there’s going to be more capital than places to put it. So, expect work comp insurers and insurance funders to keep looking to expand market share – which will keep rates low.
  2. *Except in California, where rates are up – and will stay there.
    The uncertain regulatory and judicial environment – at many levels and dealing with many aspects of comp – has made just about everyone nervous indeed about the financial future of the industry. Until there’s some clear direction and these ridiculous court cases are put to bed, the market is going to push prices up and availability down.
  3. Liberty Mutual will continue to de-emphasize workers’ comp.
    Which, given the company’s improved financial performance of late driven by personal lines’ profitability coupled with off-loading a huge chunk of legacy claims liability to Berkshire Hathaway, is a smart move.  However, this does open up opportunities for other insurers and those looking to deploy capital.
  4. Private equity’s role in the vendor market will decrease – a lot
    After years of intense interest, private equity investors’ interest in workers’ comp is waning rapidly.  There are several reasons for this, including the most obvious – the market has been over-heated for far too long.  In addition:

    1. Upheaval in the credit markets makes debt financing a lot harder to come by – and somewhat more expensive.
    2. The past consolidation means there are fewer decent-sized assets (>$10 million in EBITDA) to buy
    3. Strategic buyers are winning more of the deals because they can generate more earnings thru consolidation – United Healthcare buying Catamaran (owner of Healthcare Solutions) and Helios, EXAM buying various small companies, Xerox acquiring Stratacare, York buying MCMC are all examples.
    4. Partially due to strategics, prices have been historically high for a very long time. Double-digit multiples are likely unsustainable for much longer – and certainly not in a PE-driven marketplace.
    5. Some recent deals have not worked out so well.
  5. A half-dozen – or more – states will adopt drug formularies
    Here’s hoping they integrate formularies with utilization review and a very solid and efficient review process.
  6. Opt-Out will not gain much traction
    The bad behavior of bad actors will significantly hamper efforts to advance opt-out legislation.  That, and the lack of any real problems in most states’ workers’ comp systems.
  7. We will see a couple/several bundled payment pilots
    Gaining traction rapidly in Medicare and the group/individual health businesses, we can expect bundled payments for orthopedic care to take place in several locations. Initial reports indicate Illinois (!) and – of course – California may be on the leading edge.
  8. PBMs and payers will make even more progress reducing the use of opioids
    The work comp world has a lot to be proud of here.  After years of enabling opioid use, we – all of us – are doing a much better job stopping initial scripts, working to wean long-term users off opioids, and thereby really helping people and companies. Expect opioid use to drop again in 2016, especially for new claims.
  9. A couple of large, vertically integrated delivery systems will make significant moves into occupational medicine
    Work comp pays well (in most states), is a feeder for orthopedics, gets insured people into the health system, and diversifies revenue sources.  Delivery systems are looking for diversification, and their large infrastructure lends itself well to work comp.
  10. There will be big changes at OneCall
    With debt trading in the low eighties, pressure from debt holders on owners and management to deliver the numbers, management shuffles and continued challenges with customer service, I expect OCCM will go thru some significant changes this year.

That’s it – and I’ll check back in this summer to see how I’m doing.

What are your predictions?


Feb
1

Monday catch up

What with the HealthWonkReview Tenth Anniversary celebration at HWR HQ last week and finishing up a client project, I neglected my posting duties.

Here’s what I shoulda been writing about.

Work comp

Working with Harbor Health, the State Fund of California has launched an upgraded and updated MPN (that’s medical provider network for those not among the cognoscenti). Contracted thru Anthem, the new MPN is larger and provides more coverage in the rural areas where the State Fund has a lot of business.  While there aren’t any significant changes to how providers will interact with the State Fund, HH’s folks have determined the providers selected are higher performers.  HH will be monitoring performance on an ongoing basis.

Big news in the world of Medicare Set-Asides; NAMSAP has elected a new Board of Directors; the organization’s new leader is Gary Patureau of Louisiana Self Insured Ass’n fame.  Met Gary live for the first time last week, he’s a very experienced work comp exec; he is replacing the irreplaceable Kim Wiswell.  Rita Ayers of Tower MSA Partners is also joining the Board.

Implementing Health Reform

Contrary to the wildly wrong claims by GOP presidential candidates, employment hours have NOT changed due to ACA.  Many economists of that ideological ilk have been moaning for years that employers would cut hours to reduce the number of workers they had to insure.

Well, that hasn’t happened.  Here’s the money quote from a just-published research analysis: 

We did not see increases in 2015 in the probability of working either 25–29 hours or fewer than 25 hours per week. …We also did not observe a large reduction in 2015 (or in 2014, for that matter) in the frequency of working 30–34 hours, as one might expect if employers affected by the mandate reduced hours for workers just above the 30-hour threshold.

Update

A few weeks ago I posted on Millennium Health’s legal problems, $260 million fine and settlement with the Feds.  What I neglected to note was the settlement was with every state AND the Feds; it addressed state and federal legal actions. There have been a few announcements from individual state Attorneys General to the effect that they’ve settled with Millennium; each one was part and parcel of the one announced a few months back.  not – MH is still a consulting client.

News of the Weird 

Donald Trump said he’d save Medicare $300 billion a year by “making Medicare” negotiate drug prices. Alas, Trump doesn’t understand that this is against the law – a law passed by his own party and signed by a GOP president.

Good luck with that.

More on this here. And here.